El dolor muscular y articular se mete en la vida cotidiana casi sin pedir permiso. Muchas personas terminan preguntándose: ¿Qué tratamientos sirven realmente y cuáles solo son consejos de vecino? La realidad es que la ciencia ha ido aclarando el panorama: dejar todo en re …
As part of the deal, which still needs to be approved by regulators, Hackensack will invest about $230 million to improve Hunterdon’s facilities and roll out Epic’s electronic health record.
Hackensack Meridian, Hunterdon pen merger agreement Read More »
Abbott, which also cut its 2026 sales growth guidance, said company sales will total $42 billion following the separation.
The recurrence of violations at multiple sites led the FDA to conclude that Baxter management must improve its oversight and control of manufacturing.
FDA accuses Baxter leaders of ‘inadequate’ oversight after finding GMP failings Read More »
The major insurers are entering new Affordable Care Act markets as others are leaving the exchanges en masse, though in the cases of Centene and UnitedHealthcare, they paper over larger state exits.
Centene, Oscar, UnitedHealthcare sidle into some new counties in 2027 ACA plans Read More »
La atención al cliente ha cambiado radicalmente con la llegada de los asistentes conversacionales basados en inteligencia artificial. Las empresas que usan estas herramientas ofrecen respuestas rápidas, precisas y disponibles a cualquier hora. Este cambio no solo acorta los tiempos de …
¿Cómo aumentan los chatbots de IA la satisfacción del cliente? Read More »
Hibsago’s approval—a functional cure for certain patients with a hepatitis B infection—further validates Ionis Pharmaceuticals’ antisense platform, which has already generated two other new drug approvals this year.
China cracks down on some biotechnology ownership transfers—but will the new policy impact licensing deals?; Disc Medicine’s Phase 3 data sweep redeems rejected rare disease therapy, teeing up another FDA run; and the ESMO conference gets underway in Madrid this week, with much-anticipated data from Merck, and Summit Therapeutics.
Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners Read More »
Just one-third of patients prescribed new medicines filled them within 30 days, with a new report from the Institute for Clinical and Economic Review and West Health suggesting that cost is the problem.
Drug prices climb past $250K as US patients balk at the pharmacy Read More »
Looking for a remote biopharma position? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
